Su Z, Zou Z, Hay SI, Liu Y, Li S, Chen H, et al. Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the global burden of disease 2019 study. EClinicalMedicine. 2022;43: 101249.

Article  PubMed  PubMed Central  Google Scholar 

Stallings EB, Isenburg JL, Aggarwal D, Lupo PJ, Oster ME, Shephard H, et al. Prevalence of critical congenital heart defects and selected co-occurring congenital anomalies, 2014–2018: a U.S. population-based study. Birth Defects Res. 2022;114(2):45–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zila-Velasque JP, Grados-Espinoza P, Cubas WS, Diaz-Barrera M, Pacheco-Mendoza J. Analysis of congenital heart disease research: mapping impact, production and global collaboration. Heliyon. 2023;9(8): e19188.

Article  PubMed  PubMed Central  Google Scholar 

Tchervenkov CI, Jacobs JP, Bernier PL, Stellin G, Kurosawa H, Mavroudis C, et al. The improvement of care for paediatric and congenital cardiac disease across the world: a challenge for the world society for pediatric and congenital heart surgery. Cardiol Young. 2008;18(Suppl 2):63–9.

Article  PubMed  Google Scholar 

Hinton RB, Ware SM. Heart failure in pediatric patients with congenital heart disease. Circ Res. 2017;120(6):978–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rao PS. Management of congenital heart disease: state of the art; part I-acyanotic heart defects. Children (Basel). 2019;6(3):42.

PubMed  PubMed Central  Google Scholar 

Dabbagh A, Talebi Z, Rajaei S. Cardiovascular pharmacology in pediatric patients with congenital heart disease. In: Dabbagh A, Hernandez Conte A, Lubin LN, editors. Congenital heart disease in pediatric and adult patients: anesthetic and perioperative management. Springer International Publishing; 2023. p. 91–152.

Mondesir FL, Levitan EB, Malla G, Mukerji R, Carson AP, Safford MM, et al. Patient perspectives on factors influencing medication adherence among people with coronary heart disease (CHD) and CHD risk factors. Patient Prefer Adherence. 2019;13:2017–27.

Article  PubMed  PubMed Central  Google Scholar 

Kovacs AH, Brouillette J, Ibeziako P, Jackson JL, Kasparian NA, Kim YY, et al. Psychological outcomes and interventions for individuals with congenital heart disease: a scientific statement from the American heart association. Circ Cardiovasc Qual Outcomes. 2022;15(8): e000110.

Article  PubMed  Google Scholar 

Loss KL, Shaddy RE, Kantor PF. Recent and upcoming drug therapies for pediatric heart failure. Front Pediatr. 2021;9: 681224.

Article  PubMed  PubMed Central  Google Scholar 

Nascimento ARF, Leopoldino RWD, Santos MET, Costa TX, Martins RR. Drug-related problems in cardiac neonates under intensive care. Rev Paul Pediatr. 2020;38(3): e2018134.

Article  PubMed  PubMed Central  Google Scholar 

Tirfe M, Nedi T, Mekonnen D, Berha AB. Treatment outcome and its predictors among patients of acute heart failure at a tertiary care hospital in Ethiopia: a prospective observational study. BMC Cardiovasc Disord. 2020;20(1):1–10.

Article  Google Scholar 

Elzagallaai AA, Greff MJ, Rieder MJ. Adverse drug reactions in children: The double-edged sword of therapeutics. Clin Pharmacol Ther. 2017;101(6):725–35.

Article  CAS  PubMed  Google Scholar 

Johnson AR, Brown KM. Principles of clinical toxicology. In: Brunton LL, Knollmann BC, editors. Goodman & Gilman’s: the pharmacological basis of therapeutics. 14th ed. New York: McGraw-Hill Education; 2023. p. 155–69.

Google Scholar 

Clinical safety data management: definitions and standards for expedited reporting. London: European Medicines Agency's (EMA); 1995.

Brida M, Gatzoulis MA. Adult congenital heart disease: past, present and future. Acta Paediatr. 2019;108(10):1757–64.

Article  PubMed  Google Scholar 

Zaragoza-Macias E, Zaidi AN, Dendukuri N, Marelli A. Medical therapy for systemic right ventricles: a systematic review (part 1) for the 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e801–13.

Article  PubMed  Google Scholar 

Damkjaer M, Urhoj SK, Tan J, Briggs G, Loane M, Given JE, et al. Prescription of cardiovascular medication in children with congenital heart defects across six European regions from 2000 to 2014: data from the EUROlinkCAT population-based cohort study. BMJ Open. 2022;12(4): e057400.

Article  PubMed  PubMed Central  Google Scholar 

Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.

Article  Google Scholar 

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.

Article  PubMed  Google Scholar 

Tandircioglu UA, Turer OB, Soyer T, Ayaz E, Ozcan HN, Yigit S, et al. Effect of prostaglandin-E1 treatment on pyloric wall thickness in newborns with ductal-dependent critical congenital heart diseases. Pediatr Surg Int. 2023;39(1):144.

Article  PubMed  Google Scholar 

Rochelson E, Valdes SO, Asadourian V, Patel R, Lemming K, Howard TS, et al. Sotalol versus amiodarone for postoperative junctional tachycardia after congenital heart surgery. Heart Rhythm. 2022;19(3):450–6.

Article  PubMed  Google Scholar 

Waldvogel S, Atkinson A, Wilbeaux M, Nelle M, Berger MR, Gerull R. High dose indomethacin for patent ductus arteriosus closure increases neonatal morbidity. Am J Perinatol. 2021;38(7):707–13.

Article  PubMed  Google Scholar 

Vari D, Xiao W, Behere S, Spurrier E, Tsuda T, Baffa JM. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiol Young. 2021;31(1):63–70.

Article  PubMed  Google Scholar 

van Heugten M, van Onzenoort-Bokken L. Sildenafil citrate overdose in a 3-month postterm premature infant with pulmonary artery hypertension. Pediatr Emerg Care. 2021;37(12):e866–7.

Article  PubMed  Google Scholar 

Miyake CY, Kim JJ, Tosur M, Howard TS, Pham TDN, Valdes SO. Severe hypoglycemia associated with oral sotalol use in two children. HeartRhythm Case Rep. 2021;7(6):418–21.

Article  PubMed  PubMed Central  Google Scholar 

Ming S, Xie Y, Du X, Huang H, Fan Y, Liang Q, et al. Effect of dexmedetomidine on perioperative hemodynamics and organ protection in children with congenital heart disease: a randomized controlled trial. Medicine (Baltimore). 2021;100(1): e23998.

Article  CAS  PubMed  Google Scholar 

Hillier K, Jones K, MacInnis M, Mitra S. Comparison of standard versus high-dose ibuprofen for the treatment of hemodynamically significant patent ductus arteriosus in preterm infants. J Perinatol. 2021;41(5):1142–8.

Article  CAS  PubMed  Google Scholar 

Ana Beatriz DG, Flavia Evelyn MF, da Silva Járdila Ravana A, Danillo José CSN, Ana Flavia DMMB, José Jorge MN, et al. Periostitis after prolonged use of alprostadil in newborns with congenital cyanotic heart disease: case reports. Eur J Clin Pharm. 2021;23(1):63–6.

Google Scholar 

Afra F, Mehri M, Namazi S. Bosentan-induced immune hemolytic anemia in 17 years old man. A case report. Daru. 2021;29(1):211–5.

Article  PubMed  PubMed Central  Google Scholar 

Vaidya R, Wilson D, Paris Y, Madore L, Singh R. Use of acetaminophen for patent ductus arteriosus treatment: a single center experience. J Matern Fetal Neonatal Med. 2020;33(16):2723–9.

Article  CAS  PubMed  Google Scholar 

Sanphasitvong V, Tocharoenchok T. Appropriate dose of postoperative intravenous heparin infusion in the children undergoing modified blalock taussig shunt 4 mm and below in size. J Med Assoc Thail. 2020;103(5):12–5.

Google Scholar 

Avila ML, Shah PS, Brandao LR. Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization. Cochrane Database Syst Rev. 2020;2(2): CD010196.

PubMed  Google Scholar 

Hill AC, Silka MJ, Bar-Cohen Y. A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children. Pacing Clin Electrophysiol. 2019;42(6):670–7.

Article  PubMed  Google Scholar 

Covi S, Clark J, Delius R, Chauhan M. Amiodarone toxicity in two post-operative congenital heart disease patients. Prog Pediatr Cardiol. 2019;52:46–9.

Article  Google Scholar 

Boos V, Tietze A, Berger F, Buhrer C. Therapeutic hypothermia after perinatal asphyxia in infants with severe, ductal-dependent congenital heart disease. Pediatr Crit Care Med. 2019;20(5):457–65.

Article